Upgrade to SI Premium - Free Trial

Deciphera Pharmaceuticals (DCPH) Misses Q3 EPS by 9c

November 2, 2021 4:33 PM

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.37), $0.09 worse than the analyst estimate of ($1.28). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $23.36 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Categories

Earnings

Next Articles